FDA Drug recall D-0125-2020
Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05
- FDA Drug
- Class I
- terminated
- Published 2019-10-02
On 2019-10-02 the FDA classified a Class I recall of Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05 by Darmerica, citing label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0125-2020 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2019-09-06 |
| Published | 2019-10-02 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Darmerica |
| Distribution | US |
Product
Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707
Reason
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Identifiers
| code_info | Lot#: a) DL4654A, Exp. 04/27/21; b) DR4654, Exp. 04/27/21 c) DR4654, Exp. 04/27/21 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0125-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.